Dov A MD Goldstein's Net Worth
$1.27 Million
Who is Dov A MD Goldstein?
Dov A MD Goldstein has an estimated net worth of $1.27 Million. This is based on reported shares across multiple companies, which include VERSICOR INC, CEMPRA, INC., Esperion Therapeutics, Inc., R&R ACQUISITION VI, INC, Loxo Oncology, Inc., NeuBase Therapeutics, Inc., Coya Therapeutics, Inc., Gain Therapeutics, Inc., Durata Therapeutics, Inc., and VICURON PHARMACEUTICALS INC.
SEC CIK
Dov A MD Goldstein's CIK is 0001120478
Past Insider Trading and Trends
2015 was Dov A MD Goldstein's most active year for acquiring shares with 11 total transactions. Dov A MD Goldstein's most active month to acquire stocks was the month of May. 2015 was Dov A MD Goldstein's most active year for disposing of shares, totalling 10 transactions. Dov A MD Goldstein's most active month to dispose stocks was the month of May. 2015 saw Dov A MD Goldstein paying a total of $278,877.57 for 125,217 shares, this is the most they've acquired in one year. In 2015 Dov A MD Goldstein cashed out on 144,059 shares for a total of $1,787,000.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
VERSICOR INC No price found
CHIEF FINANCIAL OFFICER
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
CEMPRA, INC. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -150.00K |
$3.55 | -$533,115.84 |
0
|
Mar 7 - Mar 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 3
| |||
Form 4
| -41.28% | -105.46K |
$3.40 | -$358,564.00 | 150K |
Jan 13
| |||
Form 4
| -78.59% | -937.60K |
$3.41 | -$3,192,864.00 | 255.46K |
Jan 5 - Jan 6
| |||
Form 4
| -45.60% | -1.00M |
—
|
—
| 1.19M |
Mar 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
$30.06 | -$25,314.48 | 50 |
Scheduled
|
Jun 22 - Jan 4
| ||
Form 4
|
—
|
0
|
$35.74 | -$1,787,000.00 | 50 |
Scheduled
|
Jun 22
| ||
Form 4
| -33.40% | -1.10M |
—
|
—
| 2.19M |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 4
| +58.37% | 1.21M |
$6.00 | $7,281,978.00 | 3.29M |
Feb 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Esperion Therapeutics, Inc. (ESPR) Snapshot price: $1.69
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$16.47 | $214,100.00 | 47 |
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 23
| |||
Form 4
|
—
|
0
|
$3.70 | $79,442.70 | 47 |
Dec 18
| |||
Form 4
| +422.22% | 38 |
—
|
—
| 47 |
Dec 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 17
| |||
Form 4
| -48.87% | -800.00K |
$41.66 | -$33,327,088.28 | 837.13K |
Mar 21 - Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 14
| |||
Form 4
| -10.89% | -199.99K |
—
|
—
| 1.64M |
Apr 28
| |||
Form 4
| -10.58% | -217.47K |
$108.22 | -$23,534,372.60 | 1.84M |
Apr 23 - Apr 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 15
| |||
Form 4
|
∞
| 2.05M |
$14.00 |
—
| 2.05M |
Jul 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
R&R ACQUISITION VI, INC (ADMA) Snapshot price: $16.99
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4/A
|
∞
| 7.5K |
—
|
—
| 7.5K |
Feb 28
| |||
Form 4
|
∞
| 7.5K |
—
|
—
| 7.5K |
Feb 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 13
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 30
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 4
| |||
Form 4
|
∞
| 2.52M |
—
|
—
| 2.52M |
Feb 13
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |
Loxo Oncology, Inc. No price found
CFO and Treasurer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
---|---|---|---|---|---|---|---|---|---|
Form 4
| +190.75% | 43.22K |
$6.45 | $278,877.57 | 65.87K |
Apr 1 - Apr 2
| |||
Form 3/A
|
—
|
0
|
—
|
—
|
0
| ||||
Form 4
| +1,729.55% | 3.26M |
$13.00 | $5,370,001.00 | 3.45M |
Aug 6
| |||
Form 4
| +1,729.55% | 3.26M |
$13.00 | $5,370,001.00 | 3.45M |
Aug 6
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
No matching records found |